_id
694fd14cc2e91020a7bc0ba0
Ticker
RYOJ
Name
rYojbaba Co., Ltd. Common Shares
Exchange
NASDAQ
Address
4-3-1, Ohashi, Fukuoka City, Japan, 815-0033
Country
USA
Sector
Industrials
Industry
Consulting Services
Currency
USD
Website
https://ryojbaba.com
Description
rYojbaba Co., Ltd. provides consulting and health services to various customers in Japan. It operates through two segments, Consulting Services and Health Services. The Consulting Services segment offers labor and corporate consulting services to labor unions, companies to support the practice of whistleblowing and stress checks, and companies and labor unions to resolve disputes. The Health Service segment provides health services through osteopathic clinics and beauty salons to alleviate physical ailments primarily created by work related stress. rYojbaba Co., Ltd. was formerly known as Sakai Seikotsuin Co., Ltd. and changed its name to rYojbaba Co., Ltd. in October 2021. The company was founded in 2015 and is based in Fukuoka City, Japan.
Last Close
2.7
Volume
3927
Current Price
3.33
Change
0.17
Last Updated
2026-01-06T10:39:06.657Z
Ipo Date
2025-08-14T00:00:00.000Z
Market Cap
52425000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.982
Sentiment Sources
1
Current Quarter
2024-12-31
Revenue
42308
Cost Of Revenue
25634
Gross Profit
16674
Operating Expenses
8293
Operating Income
8380
Interest Expense
241.8
Pretax Income
8632
Net Income
6192
Eps
0.0005504
Dividends Per Share
-
Shares Outstanding
11250000
Income Tax Expense
2439
EBITDA
11165
Operating Margin
19.807128675427816
Total Other Income Expense Net
251.01
Cash
2605275
Short Term Investments
-
Receivables
2769715
Inventories
419.92
Total Current Assets
6473148
Property Plant Equipment
43101
Total Assets
16056968
Payables
1189896
Short Term Debt
1981411
Long Term Debt
3774930
Total Liabilities
13535656
Equity
16042
Bs_currency_symbol
USD
Depreciation
2292
Change In Working Capital
-7162
Cash From Operations
2615
Capital Expenditures
575
Cash From Investing
-573
Cash From Financing
-12611
Net Change In Cash
-8647
Cf_currency_symbol
-
PE
38.8333
PB
2335.2761501059717
ROE
38.59867846901883
ROA
0.038562697515496076
FCF
2040
Fcf Percent
0.04821783114304623
Piotroski FScore
3
Health Score
42
Deep Value Investing Score
4
Defensive Investing Score
4.5
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
3.5
Growth Investing Score
3.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
7.5
Value Investing Score
4.5
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
42308
Quarters > 0 > income Statement > cost Of Revenue
25634
Quarters > 0 > income Statement > gross Profit
16674
Quarters > 0 > income Statement > operating Expenses
8293
Quarters > 0 > income Statement > operating Income
8380
Quarters > 0 > income Statement > interest Expense
241.8
Quarters > 0 > income Statement > pretax Income
8632
Quarters > 0 > income Statement > net Income
6192
Quarters > 0 > income Statement > eps
0.0005504
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
11250000
Quarters > 0 > income Statement > income Tax Expense
2439
Quarters > 0 > income Statement > EBITDA
11165
Quarters > 0 > income Statement > operating Margin
19.807128675427816
Quarters > 0 > income Statement > total Other Income Expense Net
251.01
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
2605275
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2769715
Quarters > 0 > balance Sheet > inventories
419.92
Quarters > 0 > balance Sheet > total Current Assets
6473148
Quarters > 0 > balance Sheet > property Plant Equipment
43101
Quarters > 0 > balance Sheet > total Assets
16056968
Quarters > 0 > balance Sheet > payables
1189896
Quarters > 0 > balance Sheet > short Term Debt
1981411
Quarters > 0 > balance Sheet > long Term Debt
3774930
Quarters > 0 > balance Sheet > total Liabilities
13535656
Quarters > 0 > balance Sheet > equity
16042
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
6192
Quarters > 0 > cash Flow > depreciation
2292
Quarters > 0 > cash Flow > change In Working Capital
-7162
Quarters > 0 > cash Flow > cash From Operations
2615
Quarters > 0 > cash Flow > capital Expenditures
575
Quarters > 0 > cash Flow > cash From Investing
-573
Quarters > 0 > cash Flow > cash From Financing
-12611
Quarters > 0 > cash Flow > net Change In Cash
-8647
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.0005504
Quarters > 0 > ratios > PB
2335.2761501059717
Quarters > 0 > ratios > ROE
38.59867846901883
Quarters > 0 > ratios > ROA
0.038562697515496076
Quarters > 0 > ratios > FCF
2040
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.04821783114304623
Quarters > 0 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
11576848
Annuals > 0 > income Statement > cost Of Revenue
7119245
Annuals > 0 > income Statement > gross Profit
4457603
Annuals > 0 > income Statement > operating Expenses
2596668
Annuals > 0 > income Statement > operating Income
1860935
Annuals > 0 > income Statement > interest Expense
77274
Annuals > 0 > income Statement > pretax Income
1943423
Annuals > 0 > income Statement > net Income
1332399
Annuals > 0 > income Statement > eps
0.11843546666666667
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
11250000
Annuals > 0 > income Statement > income Tax Expense
611024
Annuals > 0 > income Statement > EBITDA
2489996
Annuals > 0 > income Statement > operating Margin
16.074625839434013
Annuals > 0 > income Statement > total Other Income Expense Net
82488
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2605275
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2769715
Annuals > 0 > balance Sheet > inventories
65995
Annuals > 0 > balance Sheet > total Current Assets
6473148
Annuals > 0 > balance Sheet > property Plant Equipment
6773870
Annuals > 0 > balance Sheet > total Assets
16056968
Annuals > 0 > balance Sheet > payables
1189896
Annuals > 0 > balance Sheet > short Term Debt
1981411
Annuals > 0 > balance Sheet > long Term Debt
3774930
Annuals > 0 > balance Sheet > total Liabilities
13535656
Annuals > 0 > balance Sheet > equity
2521312
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
1332399
Annuals > 0 > cash Flow > depreciation
469299
Annuals > 0 > cash Flow > change In Working Capital
-1716745
Annuals > 0 > cash Flow > cash From Operations
802386
Annuals > 0 > cash Flow > capital Expenditures
121243
Annuals > 0 > cash Flow > cash From Investing
-121243
Annuals > 0 > cash Flow > cash From Financing
-2429687
Annuals > 0 > cash Flow > net Change In Cash
-2170461
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
0.11843546666666667
Annuals > 0 > ratios > PB
12.671973956416341
Annuals > 0 > ratios > ROE
52.845462997042816
Annuals > 0 > ratios > ROA
8.297948902931115
Annuals > 0 > ratios > FCF
681143
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.05883665398388231
Annuals > 0 > health Score
53
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
10963365
Annuals > 1 > income Statement > cost Of Revenue
7248298
Annuals > 1 > income Statement > gross Profit
3715067
Annuals > 1 > income Statement > operating Expenses
2409866
Annuals > 1 > income Statement > operating Income
1305201
Annuals > 1 > income Statement > interest Expense
92930
Annuals > 1 > income Statement > pretax Income
1386923
Annuals > 1 > income Statement > net Income
770571
Annuals > 1 > income Statement > eps
0.0684952
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
11250000
Annuals > 1 > income Statement > income Tax Expense
616352
Annuals > 1 > income Statement > EBITDA
1813436
Annuals > 1 > income Statement > operating Margin
11.905113074316143
Annuals > 1 > income Statement > total Other Income Expense Net
81722
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
4775736
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1068444
Annuals > 1 > balance Sheet > inventories
95275
Annuals > 1 > balance Sheet > total Current Assets
6637304
Annuals > 1 > balance Sheet > property Plant Equipment
7943125
Annuals > 1 > balance Sheet > total Assets
18001363
Annuals > 1 > balance Sheet > payables
673371
Annuals > 1 > balance Sheet > short Term Debt
3084326
Annuals > 1 > balance Sheet > long Term Debt
5626252
Annuals > 1 > balance Sheet > total Liabilities
16614443
Annuals > 1 > balance Sheet > equity
1386920
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
770571
Annuals > 1 > cash Flow > depreciation
333583
Annuals > 1 > cash Flow > change In Working Capital
-2231950
Annuals > 1 > cash Flow > cash From Operations
388989
Annuals > 1 > cash Flow > capital Expenditures
1811050
Annuals > 1 > cash Flow > cash From Investing
625614
Annuals > 1 > cash Flow > cash From Financing
-1324849
Annuals > 1 > cash Flow > net Change In Cash
-657454
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.0684952
Annuals > 1 > ratios > PB
23.036656764629537
Annuals > 1 > ratios > ROE
55.55987367692441
Annuals > 1 > ratios > ROA
4.280625861497265
Annuals > 1 > ratios > FCF
-1422061
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
-0.12971026687517928
Annuals > 1 > health Score
44
Valuation > metrics > PE
38.8333
Valuation > metrics > PB
2335.2761501059717
Valuation > final Score
3.400039999999997
Valuation > verdict
38898.9% Overvalued
Profitability > metrics > ROE
38.59867846901883
Profitability > metrics > ROA
0.09565670366257654
Profitability > metrics > Net Margin
0.14635529923418739
Profitability > final Score
62
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
843.7636204961975
Risk > metrics > Interest Coverage
34.65674110835401
Risk > final Score
46
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.041160947205679
Liquidity > metrics > Quick Ratio
2.0410285349226673
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
0
Prev Valuations > 1
0
Prev Valuations > 2
0
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
0
Prev Risks > 1
0
Prev Risks > 2
0
Prev Liquidities > 0
0
Prev Liquidities > 1
0
Prev Liquidities > 2
0
Updated At
2026-01-20T23:12:47.212Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-12-15
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.04
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0.04
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-04-22
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.09
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0.09
Earnings History > 1 > surprise Percent
-
rYojbaba Co., Ltd. provides consulting and health services to various customers in Japan. It operates through two segments, Consulting Services and Health Services. The Consulting Services segment offers labor and corporate consulting services to labor unions, companies to support the practice of whistleblowing and stress checks, and companies and labor unions to resolve disputes. The Health Service segment provides health services through osteopathic clinics and beauty salons to alleviate physical ailments primarily created by work related stress. rYojbaba Co., Ltd. was formerly known as Sakai Seikotsuin Co., Ltd. and changed its name to rYojbaba Co., Ltd. in October 2021. The company was founded in 2015 and is based in Fukuoka City, Japan.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ArYojbaba (Nasdaq: RYOJ) debuts AI platform for global worker risk and labor intelligence Stock Titan
Read more →Showing 2 of 10
(Last Updated 2024-12-31)
Health Score
Price to Earnings Ratio (P/E)
-
Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of rYojbaba Co., Ltd. Common Shares
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.04
EPS Estimate
0
EPS Difference
0.04
Surprise Percent
0%
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.